Allurion Technologies ALURD
ALURD
$3.28 -0.11 (-3.24%)
At close: Aug 18, 2026 · 4:00 PM EDT

Allurion Technologies (ALURD) Net Income towards Common Stockholders (2022 - 2026)

Allurion Technologies' (ALURD) quarterly Net Income towards Common Stockholders came in at -$6.1 million in Q1 2026, down 182.6% YoY from $7.4 million in Q1 2025, and up 2.96% on a QoQ basis from -$6.3 million in Q4 2025.

Allurion Technologies (ALURD) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends

Allurion Technologies (ALURD) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$6.1 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 182.6% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.6 million (down 1750.96% YoY) and the FY2025 annual result came in at -$29.0 million, down 302.25% from the prior year.
  • Net Income towards Common Stockholders grew to -$6.1 million in Q1 2026, from -$6.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $8.7 million in Q3 2024 to a low of -$22.7 million in Q2 2023.
  • A 5-year average of -$9.5 million and a median of -$9.5 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders sank 270.65% — and 2025, when it jumped 269.69%.
  • Tracing ALURD's Net Income towards Common Stockholders over 5 years: stood at -$13.1 million in 2022, then sank by 63.53% to -$21.4 million in 2023, then surged by 55.08% to -$9.6 million in 2024, then soared by 34.63% to -$6.3 million in 2025, then gained by 2.96% to -$6.1 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$6.1 million (Q1 2026), -$6.3 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 928.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 621.86 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 201.00 Mn
10 Allurion Technologies 49.18 Mn 44.13 Mn 1.23 Mn -6.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.10 Mn
Dec 31, 2025 -6.28 Mn
Sep 30, 2025 -11.88 Mn
Jun 30, 2025 -9.34 Mn
Mar 31, 2025 7.38 Mn
Dec 31, 2024 -9.61 Mn
Sep 30, 2024 8.74 Mn
Jun 30, 2024 -8.32 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 -21.39 Mn
Sep 30, 2023 -21.89 Mn
Jun 30, 2023 -22.72 Mn
Mar 31, 2023 -18.52 Mn
Dec 31, 2022 -13.08 Mn
Sep 30, 2022 -14.31 Mn
Jun 30, 2022 -6.13 Mn